Reuters logo
BRIEF-Immunomedics announces new data for IMMU-132
January 18, 2017 / 2:17 PM / 9 months ago

BRIEF-Immunomedics announces new data for IMMU-132

Jan 18 (Reuters) - Immunomedics Inc

* Immunomedics announces new data for IMMU-132 at investor research and development day

* Immunomedics Inc - Expects to submit a Biological License Application (BLA) to FDA for accelerated approval of IMMU-132 in TNBC patients in mid-2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below